| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10900237 | Cancer Letters | 2005 | 7 Pages |
Abstract
In conclusion, tryptophan degradation is detectable in patients with gynecological cancer. The relationship between kyn/trp and neopterin concentrations indicates that cellular immune activation rather than tumor-mediated IDO-activity is responsible (228 words).
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katharina Schroecksnadel, Christiana Winkler, Lothar C. Fuith, Dietmar Fuchs,